2.Detection of BRAF V600E mutation in hairy cell leukemia by high- resolution melting analysis.
Yanru ZHANG ; Huimin LIU ; Junyuan QI ; Wei LIU ; Lugui QIU
Chinese Journal of Hematology 2014;35(3):207-209
OBJECTIVETo explore the feasibility and diagnostic implication of BRAF V600E mutation identified by high-resolution melting (HRM) assay in patients with hairy cell leukemia (HCL).
METHODSThe V600E mutation of BRAF exon 15 in four HCL patients were detected by HRM assay and patients' clinical data were retrospectively analyzed.
RESULTSAll four HCL patients were positive for the BRAF V600E mutation, which were identical to the results of DNA sequencing.
CONCLUSIONThe HRM assay for BRAF V600E mutation provides a useful tool to aid the laboratory diagnosis of HCL with easy operability, accuracy, and low cost.
Adult ; Aged ; DNA Mutational Analysis ; Female ; Humans ; Leukemia, Hairy Cell ; diagnosis ; genetics ; Male ; Middle Aged ; Mutation ; Polymerase Chain Reaction ; methods ; Proto-Oncogene Proteins B-raf ; genetics
3.Discrepant Results for BRAF V600E Mutation Among Different Specimens in a Case of Hairy Cell Leukemia.
Hee Won MOON ; Mina HUR ; Sung Hee HAN ; Yeo Min YUN ; Sung Yong KIM
Annals of Laboratory Medicine 2013;33(4):300-303
No abstract available.
Antineoplastic Agents/therapeutic use
;
Bone Marrow Cells/pathology
;
Cladribine/therapeutic use
;
DNA Mutational Analysis
;
Female
;
Humans
;
Immunophenotyping
;
Leukemia, Hairy Cell/*diagnosis/drug therapy/*genetics
;
Middle Aged
;
*Mutation
;
Proto-Oncogene Proteins B-raf/*genetics
;
Reticulin/metabolism
4.BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases.
Sang Yong SHIN ; Seung Tae LEE ; Hee Jin KIM ; Chang Seok KI ; Chul Won JUNG ; Jong Won KIM ; Sun Hee KIM
Annals of Laboratory Medicine 2015;35(2):257-259
No abstract available.
Adult
;
Aged
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Cyclophosphamide/therapeutic use
;
Doxorubicin/therapeutic use
;
Female
;
Humans
;
Immunoglobulin Variable Region/genetics
;
Leukemia, Hairy Cell/drug therapy/*genetics/pathology
;
Lymphoma, Non-Hodgkin/drug therapy/*genetics/pathology
;
MAP Kinase Kinase 1/*genetics
;
Male
;
Middle Aged
;
Mutation
;
Polymorphism, Single Nucleotide
;
Prednisone/therapeutic use
;
Pregnancy
;
Proto-Oncogene Proteins B-raf/*genetics
;
Real-Time Polymerase Chain Reaction
;
Vincristine/therapeutic use